SCHEMBL6540217

SCHEMBL6540217

COc1ccc(-c2oc(C(=O)O)nc2-c2ccc(OC)nc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.51
RCE1 Q9Y256 1/20 0.50
PPARD Q03181 5/20 0.47
TAAR1 Q96RJ0 1/20 0.45
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC6 Q9UBN7 2/20 0.42
ATR Q13535 1/20 0.42
MAP4K4 O95819 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
CHEK1 O14757 1/20 0.40
HDAC3 O15379 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6228805 0.89 MKNK1 (0.50) RCE1PPARDTAAR1MKNK1MKNK2
SCHEMBL6539905 0.88 RCE1 (0.46) NR4A2RCE1PPARDTAAR1MKNK1
SCHEMBL6208143 0.87 MEN1 (0.53) NR4A2PPARDMEN1KMT2AATR
SCHEMBL6235990 0.81 PPARD (0.43) NR4A2RCE1PPARDTAAR1MKNK1
SCHEMBL6208237 0.80 MKNK1 (0.50) NR4A2RCE1PPARDMKNK1MKNK2
SCHEMBL6539358 0.79 RCE1 (0.46) RCE1PPARDTAAR1MKNK1MKNK2
SCHEMBL6207562 0.79 RCE1 (0.46) RCE1PPARDTAAR1MKNK1MKNK2
SCHEMBL6538975 0.79 PPARD (0.49) RCE1PPARDTAAR1MEN1KMT2A
SCHEMBL6539675 0.79 MEN1 (0.51) NR4A2PPARDMKNK1MKNK2MEN1
SCHEMBL6539085 0.78 PPARD (0.54) RCE1PPARDTAAR1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 NR4A2 883/4885RCE1 337/4885PPARD 1747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.